Roche and Alnylam report positive topline results from Phase 2 study KARDIA-1 of zilebesiran
Zilebesiran demonstrated an encouraging safety and tolerability profile in adult patients with mild-to-moderate hypertension
Zilebesiran demonstrated an encouraging safety and tolerability profile in adult patients with mild-to-moderate hypertension
Strides Pharma Science Limited to acquire 100% in Strides Pharma Services Pvt Ltd.
The RCSed's Court of Regents comprises a group of distinguished and accomplished individuals in their field
The generous donation includes multiple medical equipments
This exposé embarks on an illuminative journey, unfurling the crucial stratagems imperative for upholding public health, achieved through the unyielding fortress of pharmaceutical quality safeguards
These plant locations include Ramagundam, Talcher Kaniha, Korba, Vindhyachal, Dadri, Barh, Solapur, North Karanpura, and Mauda
Sarah currently serves as the Chief Financial Officer and Principal Accounting Officer for Criteo S.A.
This study showed that patients taking 75mg of Olpasiran previously every 12 weeks presented a 40–50% reduction in LP(a)
The inspection classification was determined by the agency as Voluntary Action Indicated
Subscribe To Our Newsletter & Stay Updated